DelveInsight Evaluates a Robust Antibody-drug Conjugates in Oncology Clinical Trial Pipeline as 30+…
<!-- Name:DistributionId Value:8828892 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:True -->
<!-- Name:IcbCode Value: -->…
Browsing Tag
ADCs Market
Antibody Drug Conjugate Market, a $13.15 billion Industry by 2030 with a CAGR of 14.12 %
New York, United States, June 21, 2022 (GLOBE NEWSWIRE) -- The surge in the antibody-drug conjugates market growth is due to rising cancer cases globally, technological advancements in medical technology and the rising geriatric…